Drawbridge Health, a healthcare technology company focused on reinventing the blood draw experience, today announced that its...
infectious disease
GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine...
RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, announced the U.S. Food...
